Sepsis and coagulation

被引:46
作者
Aird, WC
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ccc.2005.04.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The host response to infection is a highly complex yet well-orchestrated process that involves an elaborate array of soluble mediators and cells. Normally, the host response prevails in containing and eliminating the pathogenic threat. When excessive or sustained, however, the host response may "turn on its bearer" and lead to organ dysfunction. Severe sepsis is invariably associated with activation of primary and secondary hemostasis. This article describes sepsis-associated changes in coagulation, discusses the putative role for these changes in pathogenesis of the sepsis syndrome, and outlines current diagnostic and therapeutic strategies.
引用
收藏
页码:417 / +
页数:16
相关论文
共 62 条
  • [1] Abraham E, 1998, LANCET, V351, P929
  • [2] The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
    Aird, WC
    [J]. BLOOD, 2003, 101 (10) : 3765 - 3777
  • [3] Natural anticoagulant inhibitors: activated protein C
    Aird, WC
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (01) : 161 - 182
  • [4] The hematologic system as a marker of organ dysfunction in sepsis
    Aird, WC
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (07) : 869 - 881
  • [5] Vascular bed-specific hemostasis: Role of endothelium in pathogenesis
    Aird, WC
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : S28 - S34
  • [6] Time course of platelet counts in critically ill patients
    Akca, S
    Haji-Michael, P
    de Mendonça, A
    Suter, P
    Levi, M
    Vincent, JL
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (04) : 753 - 756
  • [7] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [8] Deep vein thrombosis and its prevention in critically ill adults
    Attia, J
    Ray, JG
    Cook, DJ
    Douketis, J
    Ginsberg, JS
    Geerts, WH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (10) : 1268 - 1279
  • [9] Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis
    Bernard, GR
    Ely, EW
    Wright, TJ
    Fraiz, J
    Stasek, JE
    Russell, JA
    Mayers, I
    Rosenfeld, BA
    Morris, PE
    Yan, SB
    Helterbrand, JD
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (11) : 2051 - 2059
  • [10] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709